MetaKTSP: A meta-analytic top scoring pair method for robust cross-study validation of omics prediction analysis

Bioinformatics

Volumn 32, Issue 13, 2016, Pages 1966-1973

  Kim, Sung Hwan ^a,b   Lin, Chien Wei ^a   Tseng, George C ^a,c,d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b Korea University   (South Korea)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BREAST TUMOR; DNA METHYLATION; FIBROSING ALVEOLITIS; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HUMAN; META ANALYSIS (TOPIC); METHODOLOGY; PROCEDURES; PROGNOSIS; SUPERVISED MACHINE LEARNING; VALIDATION STUDY;

ALGORITHMS; BREAST NEOPLASMS; DNA METHYLATION; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; META-ANALYSIS AS TOPIC; PROGNOSIS; RESEARCH DESIGN; SUPERVISED MACHINE LEARNING;

EID: 85007227258     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btw115     Document Type: Article

References (53)

1. Afsari,B. et al. (2014) Rank discriminants for predicting phenotypes from RNA expression. Ann. Appl. Stat., 8, 1469-1491.
2. Benito,M. et al. (2004) Adjustment of systematic microarray data biases. Bioinformatics, 20, i105-i114.
3. Bernau,C. et al. (2014) Cross-study validation for the assessment of prediction algorithms. Bioinformatics, 30, i105-i112.
4. Cheng,C. et al. (2009) Ratio adjustment and calibration scheme for gene-wise normalization to enhance microarray inter-study prediction. Bioinformatics, 25, 1655-1661.
5. Correa,G. and Reis-Filho,J. (2009) Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? Int. J. Surg. Pathol., 17, 285-302.
6. Dvorkin-Gheva,A. and Hassell,J. (2011) Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples. Plos One, 6, e26023.
7. Fisher,R.A. (1925) Statistical Methods for Research Workers. Oliver and Boyd (Edinburgh).
8. Fisher,R. (1948) Questions and answers #14. Am. Stat., 2, 30-31.
9. Garrett-Mayer,E. et al. (2008) Cross-study validation and combined analysis of gene expression microarray data. Biostatistics, 9, 333-354.
10. Geman,D. et al. (2004) Expression Profiles from Pairwise mRNA Comparisons. Stat. Appl. Genet. Mol. Biol., 3, article 19.
11. Kern,S. (2012) Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. Cancer Res., 72, 6097-6101.
12. Kang,D. et al. (2012) MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis. Nucleic Acids Res., 40, e15.
13. Kuo,W. et al. (2006) A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies. Nat. Biotechnol., 24, 832-840.
14. Ma,S. et al. (2014) Measuring the effect of inter-study variability on estimating prediction error. PLoS One, 9, e110840.
15. Ma,X. et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell, 5, 607-616.
16. Marchionni,L. et al. (2013) A simple and reproducible breast cancer prognostic test. BMC Genomics, 17, 336.
17. MAQC Consortium et al. (2006) The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol., 24, 1151-1161.
18. McShane,L. and Polley,M. Development of omics-based clinical tests for prognosis and therapy selection: The challenge of achieving statistical robustness and clinical utility. Clin. Trials, 10, 653-665.
19. Mi,Z. et al. (2010) Module-based prediction approach for robust inter-study predictions in microarray data. Bioinformatics, 26, 2586-2593.
20. Mitchell,S. et al. (2004) Inter-platform comparability of microarrays in acute lymphoblastic leukemia. BMC Genomics, 5, 71.
21. Morris,M. et al. (2011) Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene, 30, 1390-1401.
22. Opitz,D. and Maclin,R. (1999) Popular ensemble methods: an empirical study. J. Artif. Intell. Res., 11, 169-198.
23. Owen,A.B. (2009) Karl Pearson's meta-analysis revisited. Ann. Stat., 37, 3867-3892.
24. Paik,S. et al. (2004) A multigene assay to predict recurrence of tamoxifentreated, node-negative breast cancer. N. Engl. J. Med., 351, 2817-2826.
25. Parker,J. et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol., 27, 1160-1167.
26. Parris,T. et al. (2010) Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma. Clin. Cancer Res., 16, 3860-3874.
27. Powe, D. et al. (2014) DACH1: its role as a classifier of long term good prognosis in luminal breast cancer. PLoS One, 9, e84428.
28. Price,N. et al. (2007) Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc. Natl. Acad. Sci. USA, 104, 3414-3419.
29. Ramaswamy, S. et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA, 15149-15154.
30. Raponi,M. et al. (2008) A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acutemyeloid leukemia. Blood, 5, 2589-2596.
31. Ray,P. et al. (2010) FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res., 70, 3870-3876.
32. Reid,J. et al. (2005) Limits of predictive models using microarray data for breast cancer clinical treatment outcome. J. Natl. Cancer Inst., 97, 927-930.
33. Sato,F. et al. (2009) Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One, 4, e5540.
34. Shabalin,A. et al. (2008) Merging two gene-expression studies via cross-platform normalization. Bioinformatics, 24, 1154-1160.
35. Stouffer,S. (1949) The American Soldier: Adjustment during Army Life, Vol. 1. Princeton: Princeton University Press.
36. Slawski,M. et al. (2008) CMA: A comprehensive Bioconductor package for supervised classification with high dimensional data. BMC Bioinformatics, 9, 439.
37. Smith,D. et al. (2008) Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation. BMC Bioinformatics, 28, 63.
38. Symmans,W. et al. (2010) Genomic index of sensitivity to endocrine therapy for breast cancer. J. Clin. Oncol., 28, 4111-4119.
39. Tan,A. et al. (2005) Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics, 21, 3896-3904.
40. Teng,S. et al. (2007) A statistical framework to infer functional gene associations from multiple biologically interrelated microarray experiments. J. Am. Stat. Assoc., 104, 465-473.
41. Thakkar,A. et al. (2010) Identification of gene expression signature in estrogen receptor positive breast carcinoma. Biomark. Cancer, 2, 1-15.
42. Tordai,A. et al. (2008) Evaluation of biological pathways involved in chemotherapy response in breast cancer. Breast Cancer Res., 10, R37.
43. Tseng,G. et al. (2012) Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Res., 40, 3785-3799.
44. Usary,J. et al. (2004) Mutation of GATA3 in human breast tumors. Oncogene, 23, 7669-7678.
45. van de Vijver,M. et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med., 347, 1999-2009.
46. van Roosmalen,W. et al. (2015) Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant. J. Clin. Invest., 125, 1648-1664.
47. van't Veer,L. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
48. Wang,X. et al. (2012) Detecting disease-associated genes with confounding variable adjustment and the impact on genomic meta-analysis: With application to major depressive disorder.BMC Bioinformatics, 13, 13-52.
49. Xu,L. et al. (2005) Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data. Bioinformatics, 20, 3905-3911.
50. Xu,L. et al. (2008) Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinformatics, 9, 125.
51. Yu,J. et al. (2008) PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene., 27, 4657-4665.
52. Zhang,D. et al. (2012) Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer. Oncol. Rep., 28, 1785-1791.
53. Zhang,Y. et al. (2013) Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early-and late-distant recurrence. Clin. Cancer Res., 19, 4196-4205.